This expert-led course provides an overview of pharmacology broken down into five sections. The first four sections cover cytotoxic therapies, overviewing DNA-damaging agents, microtubule toxins, and antimetabolites. The fifth section focuses on drug interactions in oncology and their importance in patient care.
- Describe the mechanistic action of different DNA-damaging agents and apply knowledge of DNA-damaging agents to anticipate side effects and learn common toxicities
- Describe the mechanistic action of different microtubule toxins and antimetabolites and apply knowledge of microtubule toxins and antimetabolites to anticipate side effects and learn common toxicities
- Briefly describe pathways of drug-drug interactions in oncology
Continuing Education Credit
2.5 Credits/Points are available for participation in this course. Certificate and credit types available include:
- AMA PRA Category 1 Credits™
- ABIM MOC Points
- CNE Contact Hours
- ONCC ILNA Points in Treatment Modalities
- CPE Credits
- Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
- Certificate of Completion may be used to document participation, but no credit will be conferred.
- This course expires on March 23, 2019. Participants must complete all necessary course components by this date to receive credit.